Cargando…

Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study

The restriction enzyme-based digital methylation-specific polymerase chain reaction (RE-dMSP) assay is useful for diagnosing sentinel lymph node (SN) metastasis in patients with breast cancer, by detecting tumor-derived methylated Ras association domain-containing protein 1 (RASSF1A). In addition, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sung Ae, Masunaga, Nanae, Kagara, Naofumi, Ohi, Yasuyo, Gondo, Naomi, Abe, Kaori, Yoshinami, Tetsuhiro, Sota, Yoshiaki, Miyake, Tomohiro, Tanei, Tomonori, Shimoda, Masafumi, Sagara, Yasuaki, Shimazu, Kenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551867/ https://www.ncbi.nlm.nih.gov/pubmed/37809046 http://dx.doi.org/10.3892/ol.2023.14063

Ejemplares similares

Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR
por: Hashimoto, Yoko, et al.
Publicado: (2023)

A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer
por: Abe, Kaori, et al.
Publicado: (2022)

Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation
por: Abe, Mizuho, et al.
Publicado: (2019)

Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases
por: Hashizume, Sakina, et al.
Publicado: (2022)

Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer
por: Yoshinami, Tetsuhiro, et al.
Publicado: (2020)

Molecular Barcode Sequencing of the Whole Ligand Binding Domain of the ESR1 Gene in Cell-Free DNA from Patients with Metastatic Breast Cancer()
por: Masunaga, Nanae, et al.
Publicado: (2020)

Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
por: Sato, Yasufumi, et al.
Publicado: (2021)

Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
por: Hori, Ami, et al.
Publicado: (2019)

Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer
por: Kim, Seung Jin, et al.
Publicado: (2020)

Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression
por: Shimoda, Masafumi, et al.
Publicado: (2017)

Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients
por: Mishima, Chieko, et al.
Publicado: (2015)

Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals
por: Shimazu, Kenzo, et al.
Publicado: (2017)

BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer
por: Otani, Yoko, et al.
Publicado: (2014)

Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis
por: Shimazu, Kenzo, et al.
Publicado: (2018)

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis
por: FUJITA, NORIKO, et al.
Publicado: (2014)

Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
por: Umekita, Yoshihisa, et al.
Publicado: (2011)

Emerging Technologies for Real‐Time Intraoperative Margin Assessment in Future Breast‐Conserving Surgery
por: Pradipta, Ambara R., et al.
Publicado: (2020)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Clinical Significance of Occult Micrometastases in Axillary Lymph Nodes in “Node‐negative” Breast Cancer Patients
por: Umekita, Yoshihisa, et al.
Publicado: (2002)

Mucocele-like lesions of the breast: a long-term follow-up study
por: Ohi, Yasuyo, et al.
Publicado: (2011)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
por: Hida, Akira I., et al.
Publicado: (2016)

Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer
por: Ohi, Y, et al.
Publicado: (2012)

A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study
por: Osako, Tomo, et al.
Publicado: (2022)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

ODP559 The prognostic role of IL-17A-neutrophils crosstalk in triple-negative breast cancer
por: Khalid, Freeha, et al.
Publicado: (2022)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast
por: Yoda, Tomomi, et al.
Publicado: (2014)

The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
por: Polesello, Cedric, et al.
Publicado: (2006)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

The Role of RASSF1C in the Tumor Microenvironment
por: Amaar, Yousef G., et al.
Publicado: (2023)

Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer
por: Shibata, Nobuhiro, et al.
Publicado: (2023)

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
por: Ohtani, Shoichiro, et al.
Publicado: (2018)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h3qm86vj6kvcmpe0uf0rv8p06c